Role of receptor for advanced glycation end products (RAGE) in liver disease

Area of Science:

• * Molecular biology and cell signaling.
• * Immunology and cellular stress responses.
• * Hepatology and disease pathology.

Background:

• * Receptor for Advanced Glycation End Products (RAGE) is a cell surface molecule binding multiple ligands.
• * RAGE activation triggers intracellular signaling cascades involved in inflammation, proliferation, apoptosis, angiogenesis, migration, and fibrosis.
• * RAGE is expressed in liver cells, including hepatic stellate cells, hepatocytes, and hepatoma cells.

Purpose of the Study:

• * To summarize the pathological role of RAGE in diverse liver diseases.
• * To explore RAGE's involvement in hepatic insulin resistance, steatosis, fibrosis, and injury.
• * To review therapeutic interventions targeting the RAGE pathway for liver disorders.

Main Methods:

• * Review of existing scientific literature on RAGE and liver diseases.
• * Analysis of RAGE's role in cellular functions and signaling pathways.
• * Synthesis of evidence linking RAGE activation to hepatic pathology.

Main Results:

• * RAGE engagement with ligands induces oxidative stress and activates downstream pathways in the liver.
• * RAGE signaling contributes to the development and progression of hepatic insulin resistance, steatosis, fibrosis, and hepatocellular carcinoma.
• * Evidence suggests RAGE is implicated in both ischemic and non-ischemic liver injury.

Conclusions:

• * The RAGE signaling pathway plays a significant pathological role in various liver diseases.
• * Targeting RAGE offers a promising novel therapeutic avenue for managing hepatic disorders.
• * Further research into RAGE inhibition could lead to effective treatments for liver conditions.